Hiive Lightmatter II a Series of Hiive Lightmatter LLC
Raised
$3M
Investors
54
Min Invest
$0
AltStreet Analysis
·Generated from EDGAR primary sources
Hiive Lightmatter II, a Delaware series LLC filed by LLC Sydecar with executive officer Brett Sagan, raised $2.6M from 54 investors under Rule 506(b) and Section 3(c)(1) exemptions. The offering has no stated minimum investment and represents a pooled investment fund vehicle within the Hiive platform ecosystem, which operates 69 related EDGAR entities focused on private equity investments.
This 506(b) pooled investment fund follows typical private equity SPV structuring with 3(c)(1) Investment Company Act exemption, allowing up to 100 accredited investors. The $0 minimum investment and 54-investor count ($48K average check size) suggests broad retail-tier access, which is relatively uncommon in traditional private equity but increasingly typical for platform-enabled deal-by-deal SPV models.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Sydecar LLC
Director · Claymont, DE
Brett Sagan
Executive Officer · Claymont, DE
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
